2026 NPPES data Research Study Specialist NPI 1720227143 PA-C
Verify on CMS →

YONGZHONG WEI, PA-C

Research Study Specialist in SAINT LOUIS, Missouri. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
585
Medicare Part D claims · 155 beneficiaries · Research Study Specialist avg: 601
Industry payments
$2.2K
134 payments · CMS Open Payments (Sunshine Act)

What the federal data shows

YONGZHONG WEI, PA-C filed 585 Medicare Part D claims in 2023 as a Research Study Specialist in SAINT LOUIS, Missouri.

585
Part D claims, 2023
$2.2K
industry payments (Sunshine Act)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

YONGZHONG WEI, PA-C's Medicare Part D volume vs every U.S. prescriber

Total Medicare Part D claims, 2023 — across all CMS prescribers nationally

585 Top 34% higher than 66% of 1,370,886 prescribers

0–200: 670,926 prescribers (49%). Below this entry. 200–400: 182,923 prescribers (13%). Below this entry. 400–600: 90,619 prescribers (7%). This entry sits in this band. 600–800: 56,224 prescribers (4%). Above this entry. 800–1,000: 40,919 prescribers (3%). Above this entry. 1,000–1,200: 31,827 prescribers (2%). Above this entry. 1,200–1,400: 26,224 prescribers (2%). Above this entry. 1,400–1,600: 21,710 prescribers (2%). Above this entry. 1,600–1,800: 19,072 prescribers (1%). Above this entry. 1,800–2,000: 16,451 prescribers (1%). Above this entry. 2,000–2,200: 213,991 prescribers (16%). Above this entry. This provider 0 2K+ every Part D prescriber (claims/yr), bucketed by value

Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Medicare Part D Prescriber Public Use File · 2023

What does the federal data show about YONGZHONG WEI, PA-C?

Quality data not reported

NPI registry status

Active

Issued 02/09/2009

NPI 1720227143

Primary specialty

Research Study Specialist

Rare

472 US NPIs in this specialty

Medicare Part D claims

585 3% vs specialty avg

2023 prescription claims

Specialty avg: 601

Specialty distribution in Missouri

How Research Study Specialist compares to other specialties among Missouri providers

Missouri providers

Research Study Specialist share within Missouri

1. Research Study Specialist42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Research Study Specialist share within Missouri

Specialty board-certification context

Estimated specialty board-certified rate — Research Study Specialist (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Research Study Specialist ABMS/AOA estimate

Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Research Study Specialist) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

YONGZHONG WEI, PA-C is a Research Study Specialist provider practicing in SAINT LOUIS, Missouri, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: PA-C. NPI: 1720227143. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

YONGZHONG WEI, PA-C appears in the CMS NPPES registry as a Research Study Specialist provider holding PA-C credentials at 3009 N BALLAS RD STE 105B, SAINT LOUIS, MO, 63131, with a listed phone of (314) 996-7960. NPI 1720227143 was issued on 02/09/2009. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WEI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 585 prescription claims written by this provider, covering 155 Medicare beneficiaries and totaling roughly $190K in drug spend. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Research Study Specialist is a narrow specialty nationwide, with 472 enrolled providers across 41 states and an average of 601 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

3009 N BALLAS RD STE 105B
SAINT LOUIS, MO 63131

Provider Details

NPI 1720227143
Specialty Research Study Specialist
Credentials PA-C
Gender Male
NPI Issued 02/09/2009

Hospital and facility affiliations

Facilities where YONGZHONG WEI, PA-C bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

PHYSICIAN GROUPS LC
SAINT LOUIS, MO

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

Industry payments received (2024) — CMS Open Payments transparency data

The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for YONGZHONG WEI, PA-C. Source: openpaymentsdata.cms.gov.

Total received

$2.2K

Largest payer

Novartis Pharmaceuticals Corporation

Most common payment type

Food and Beverage

Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

585
Total Claims
$190K
Total Drug Cost
155
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
745
Total Day Supply
21,273
Generic Drug Cost
$54K

Patient Demographics

Average Patient Age
61.5 years
Avg HCC Risk Score
1.75
Gender Split
77% female / 23% male
Age Distribution
<65: 77, 65-74: 55, 75-84: N/A, 85+: N/A

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Pregabalin
71
Modafinil
68
Gabapentin
48
Baclofen
36
Diazepam
27
Divalproex Sodium
26
Levetiracetam
19
Carbamazepine Er
Carbamazepine
15
Temazepam
15
Oxybutynin Chloride Er
Oxybutynin Chloride
14

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Research Study Specialist Overview

How YONGZHONG WEI, PA-C fits within the Research Study Specialist landscape nationally.

472
Research Study Specialist Providers in US
41
States with Research Study Specialist
601
Avg Claims per Provider

YONGZHONG WEI, PA-C's 585 claims are below the specialty average of 601.

Nearby Research Study Specialist Providers in Missouri

Other clinicians with the same primary specialty enrolled in Missouri, drawn from the same CMS NPPES roster as WEI.

Compare Research Study Specialist nationally: see state-by-state distribution →

Frequently Asked Questions

What is YONGZHONG WEI, PA-C's specialty?
YONGZHONG WEI, PA-C specializes in Research Study Specialist and practices in SAINT LOUIS, Missouri. Credentials: PA-C.
How much does YONGZHONG WEI, PA-C prescribe under Medicare Part D?
In 2023, YONGZHONG WEI, PA-C wrote 585 Medicare Part D claims totaling $190K in drug costs for 155 beneficiaries.
Where is YONGZHONG WEI, PA-C located?
YONGZHONG WEI, PA-C is located at 3009 N BALLAS RD STE 105B, SAINT LOUIS, MO, 63131. Phone: (314) 996-7960.
What is YONGZHONG WEI, PA-C's NPI number?
YONGZHONG WEI, PA-C's National Provider Identifier (NPI) is 1720227143, issued on 02/09/2009.
How many Research Study Specialist providers are there in the US?
There are 472 Research Study Specialist providers across 41 states in the US. The average Research Study Specialist provider writes 601 Medicare Part D claims per year.
What drugs does YONGZHONG WEI, PA-C prescribe most often?
Based on 2023 Medicare Part D data, YONGZHONG WEI, PA-C's most frequently prescribed drugs include Pregabalin, Modafinil, Gabapentin. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does YONGZHONG WEI, PA-C accept Medicare?
YONGZHONG WEI, PA-C appears in CMS Medicare data with 585 Part D claims and 155 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify YONGZHONG WEI, PA-C's credentials?
YONGZHONG WEI, PA-C's NPI is 1720227143 with credentials PA-C. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology